BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15471831)

  • 21. Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
    Piao Y; Cao C; Xu Y; Huang S; Jiang F; Jin T; Jin Q; Hua Y; Hu Q; Chen X
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):353-359. PubMed ID: 33782748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
    Yen TC; Lin CY; Wang HM; Huang SF; Liao CT; Kang CJ; Ng SH; Chan SC; Fan KH; Chen IH; Lin WJ; Cheng AJ; Chang JT
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1307-14. PubMed ID: 16863922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography.
    Kao CH; Shiau YC; Shen YY; Yen RF
    Cancer; 2002 Apr; 94(7):1981-6. PubMed ID: 11932900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.
    Yen RF; Ting LL; Cheng MF; Wu YW; Tzen KY; Hong RL
    Head Neck; 2009 Jun; 31(6):717-24. PubMed ID: 19189341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
    Khan N; Oriuchi N; Yoshizaki A; Kanuma T; Higuchi T; Endo K
    Ann Nucl Med; 2005 Apr; 19(2):137-45. PubMed ID: 15909494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.
    Kao CH; ChangLai SP; Chieng PU; Yen RF; Yen TC
    J Clin Oncol; 1998 Nov; 16(11):3550-5. PubMed ID: 9817274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
    Dresel S; Grammerstorff J; Schwenzer K; Brinkbäumer K; Schmid R; Pfluger T; Hahn K
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):995-1003. PubMed ID: 12739070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG PET in detecting primary and recurrent malignant salivary gland tumors.
    Cermik TF; Mavi A; Acikgoz G; Houseni M; Dadparvar S; Alavi A
    Clin Nucl Med; 2007 Apr; 32(4):286-91. PubMed ID: 17413575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of simultaneous whole-body
    Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy.
    Tsai MH; Shiau YC; Kao CH; Shen YY; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 May; 128(5):279-82. PubMed ID: 12029444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
    Yu DF; Zuo CT; Dai JZ; Dong MJ; Zhao J; Lin XT; Guan YH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1538-41. PubMed ID: 15566675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.
    Yen RF; Yen MF; Hong RL; Tzen KY; Chien CR; Chen TH
    Acad Radiol; 2009 Jan; 16(1):54-60. PubMed ID: 19064212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
    Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
    Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
    Johnson GR; Zhuang H; Khan J; Chiang SB; Alavi A
    Clin Nucl Med; 2003 Oct; 28(10):815-20. PubMed ID: 14508272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings.
    Tsai MH; Huang WS; Tsai JJ; Chen YK; Changlai SP; Kao CH
    Anticancer Res; 2003; 23(4):3513-6. PubMed ID: 12926100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis.
    Zhou H; Shen G; Zhang W; Cai H; Zhou Y; Li L
    J Nucl Med; 2016 Mar; 57(3):342-7. PubMed ID: 26541775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.